Mass Spectrometry-based Quantitative Proteomic Profiling of Human Pancreatic and Hepatic Stellate Cell Lines

Genomics, Proteomics and Bioinformatics

Volumn 11, Issue 2, 2013, Pages 105-113

  Paulo, Joao A ^a,b,c   Kadiyala, Vivek ^b   Banks, Peter A ^b   Conwell, Darwin L ^b   Steen, Hanno ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Fibrosis; Pancreas; Proteomics; Tandem mass tag

Indexed keywords

ACTIN; ACTIN DEPOLYMERIZING FACTOR; LACTATE DEHYDROGENASE; RIBONUCLEOPROTEIN; UBIQUITIN THIOLESTERASE;

ARTICLE; CELL ASSAY; CELL IMMORTALIZATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PANCREATIC STELLATE CELL; PROTEIN ANALYSIS; PROTEOMICS; STELLATE CELL;

CELL LINE; HEPATIC STELLATE CELLS; HUMANS; MASS SPECTROMETRY; PANCREATIC STELLATE CELLS; PROTEOME; TRANSCRIPTOME;

EID: 84876806581     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2013.01.009     Document Type: Article

References (57)

1. Erkan M., Adler G., Apte M.V., Bachem M.G., Buchholz M., Detlefsen S., et al. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012, 61:172-178.
2. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008, 88:125-172.
3. Omary M.B., Lugea A., Lowe A.W., Pandol S.J. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007, 117:50-59.
4. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001, 21:311-335.
5. Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
6. Apte M.V., Haber P.S., Applegate T.L., Norton I.D., McCaughan G.W., Korsten M.A., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998, 43:128-133.
7. Kordes C., Sawitza I., Häussinger D. Hepatic and pancreatic stellate cells in focus. Biol Chem 2009, 390:1003-1012.
8. Suematsu M., Aiso S. Professor Toshio Ito: a clairvoyant in pericyte biology. Keio J Med 2001, 50:66-71.
9. Moreira R. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007, 131:1728-1734.
10. Gressner A.M., Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006, 10:76-99.
11. Safadi R., Friedman S.L. Hepatic fibrosis - role of hepatic stellate cell activation. MedGenMed 2002, 4:27.
12. Bataller R., Brenner D.A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001, 21:437-451.
13. Haber P.S., Keogh G.W., Apte M.V., Moran C.S., Stewart N.L., Crawford D.H., et al. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 1999, 155:1087-1095.
14. Friedman S.L. Stellate cell activation in alcoholic fibrosis - an overview. Alcohol Clin Exp Res 1999, 23:904-910.
15. Deng X., Liang J., Lin Z.X., Wu F.S., Zhang Y.P., Zhang Z.W. Natural taurine promotes apoptosis of human hepatic stellate cells in proteomics analysis. World J Gastroenterol 2010, 16:1916-1923.
16. Bosselut N., Housset C., Marcelo P., Rey C., Burmester T., Vinh J., et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 2010, 10:1017-1028.
17. Molleken C., Sitek B., Henkel C., Poschmann G., Sipos B., Wiese S., et al. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 2009, 49:1257-1266.
18. Kim P.K., Kim M.R., Kim H.J., Yoo H.S., Kim J.S., Cho E.H., et al. Proteome analysis of the rat hepatic stellate cells under high concentrations of glucose. Proteomics 2007, 7:2184-2188.
19. Gressner O.A., Weiskirchen R., Gressner A.M. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007, 381:107-113.
20. Kawada N. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype. Methods Mol Med 2005, 117:371-379.
21. Paulo J.A., Urrutia R., Banks P.A., Conwell D.L., Steen H. Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS). J Proteomics 2011, 75:708-717.
22. Paulo J.A., Urrutia R., Banks P.A., Conwell D.L., Steen H. Proteomic analysis of an immortalized mouse pancreatic stellate cell line identifies differentially-expressed proteins in activated vs nonproliferating cell states. J Proteome Res 2011, 10:4835-4844.
23. Wehr A.Y., Furth E.E., Sangar V., Blair I.A., Yu K.H. Analysis of the human pancreatic stellate cell secreted proteome. Pancreas 2011, 40:557-566.
24. Mathison A., Liebl A., Bharucha J., Mukhopadhyay D., Lomberk G., Shah V., et al. Pancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes. Pancreatology 2010, 10:505-516.
25. Buchholz M., Kestler H.A., Holzmann K., Ellenrieder V., Schneiderhan W., Siech M., et al. Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med (Berl) 2005, 83:795-805.
26. Thompson A., Schafer J., Kuhn K., Kienle S., Schwarz J., Schmidt G., et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003, 75:1895-1904.
27. Hutson S. Structure and function of branched chain aminotransferases. Prog Nucleic Acid Res Mol Biol 2001, 70:175-206.
28. Torres N., Vargas C., Hernandez-Pando R., Orozco H., Hutson S.M., Tovar A.R. Ontogeny and subcellular localization of rat liver mitochondrial branched chain amino-acid aminotransferase. Eur J Biochem 2001, 268:6132-6139.
29. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995, 57:289-300.
30. Thomas P.D., Kejariwal A., Campbell M.J., Mi H., Diemer K., Guo N., et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003, 31:334-341.
31. Griffin T.J., Gygi S.P., Ideker T., Rist B., Eng J., Hood L., et al. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 2002, 1:323-333.
32. Foss E.J., Radulovic D., Shaffer S.A., Ruderfer D.M., Bedalov A., Goodlett D.R., et al. Genetic basis of proteome variation in yeast. Nat Genet 2007, 39:1369-1375.
33. Fu J., Keurentjes J.J., Bouwmeester H., America T., Verstappen F.W., Ward J.L., et al. System-wide molecular evidence for phenotypic buffering in Arabidopsis. Nat Genet 2009, 41:166-167.
34. Ghazalpour A., Bennett B., Petyuk V.A., Orozco L., Hagopian R., Mungrue I.N., et al. Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet 2011, 7:e1001393.
35. Mak K.M., Chu E., Lau K.H., Kwong A.J. Liver fibrosis in elderly cadavers: localization of collagen types I, III, and IV, alpha-smooth muscle actin, and elastic fibers. Anat Rec (Hoboken) 2012, 295:1159-1167.
36. Zakaria S., Youssef M., Moussa M., Akl M., El-Ahwany E., El-Raziky M., et al. Value of alpha-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection. Arch Med Sci 2010, 6:356-365.
37. Nouchi T., Tanaka Y., Tsukada T., Sato C., Marumo F. Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 1991, 11:100-105.
38. Matsubara K., Suda K., Suzuki F., Kumasaka T., Shiotsu H., Miyano T. Alpha-Smooth muscle actin immunoreactivity may change in nature in interlobular fibrosis of the pancreas in patients with congenital biliary dilatation. Pathol Int 2004, 54:498-502.
39. Apte M., Pirola R., Wilson J. The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells. Antioxid Redox Signal 2011, 15:2711-2722.
40. Xu Z., Vonlaufen A., Phillips P.A., Fiala-Beer E., Zhang X., Yang L., et al. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 2010, 177:2585-2596.
41. Klose T., Abiatari I., Samkharadze T., De Oliveira T., Jäger C., Kiladze M., et al. The actin binding protein destrin is associated with growth and perineural invasion of pancreatic cancer. Pancreatology 2012, 12:350-357.
42. Cheng Z., Wang K., Wei J., Lu X., Liu B. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells. Phytomedicine 2010, 17:1000-1005.
43. Ng E.K., Lee S.M., Li H.Y., Ngai S.M., Tsui S.K., Waye M.M., et al. Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1). J Cell Biochem 2001, 82:1-10.
44. Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol 2013. doi: doi:10.1007/s13277-013-0679-1.
45. Gong B., Cao Z., Zheng P., Vitolo O.V., Liu S., Staniszewski A., et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126:775-788.
46. Lien H.C., Wang C.C., Huang C.S., Yang Y.W., Kuo W.H., Yao Y.T. Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors. Virchows Arch 2013, 462:155-161.
47. Tsai R.Y., McKay R.D. Cell contact regulates fate choice by cortical stem cells. J Neurosci 2000, 20:3725-3735.
48. Seaberg R.M., Smukler S.R., Kieffer T.J., Enikolopov G., Asghar Z., Wheeler M.B., et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotech 2004, 22:1115-1124.
49. Baba S., Fujii H., Hirose T., Yasuchika K., Azuma H., Hoppo T., et al. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004, 40:255-260.
50. Xu L., Hui A., Albanis E., Arthur M., O'Byrne S., Blaner W., et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54:142-151.
51. Jesnowski R., Furst D., Ringel J., Chen Y., Schrodel A., Kleeff J., et al. Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine. Lab Invest 2005, 85:1276-1291.
52. Carr S., Aebersold R., Baldwin M., Burlingame A., Clauser K., Nesvizhskii A., et al. The need for guidelines in publication of peptide and protein identification data: working group on publication guidelines for peptide and protein identification data. Mol Cell Proteomics 2004, 3:531-533.
53. Taylor G.K., Goodlett D.R. Rules governing protein identification by mass spectrometry. Rapid Commun Mass Spectrom 2005, 19:3420.
54. Wilkins M.R., Appel R.D., Van Eyk J.E., Chung M.C., Gorg A., Hecker M., et al. Guidelines for the next 10years of proteomics. Proteomics 2006, 6:4-8.
55. Elias J.E., Gibbons F.D., King O.D., Roth F.P., Gygi S.P. Intensity-based protein identification by machine learning from a library of tandem mass spectra. Nat Biotechnol 2004, 22:214-219.
56. Moore R.E., Young M.K., Lee T.D. Method for screening peptide fragment ion mass spectra prior to database searching. J Am Soc Mass Spectrom 2000, 11:422-426.
57. Cui X., Churchill G.A. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 2003, 4:210.